A 4852New Jersey

Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Became law

Jul 8, 2026: Approved P.L.2026, c.40.

Follow this bill Ratifi